The early temporary reimbursement of Belgium and its enlightenment to ChinaSHEN Jie, JIANG Rong, SHAO Rong2721-2725
Status analysis of the protection and utilization of human genetic resources in ChinaLI Ping-ping, PAN Zi-qi2731-2734
Strategy of overseas patent layout in the field of medicineXUE Ya-ping, TAN Yu-mei, MAO Hong-fen, LAO Jin-hua, LIN Tao-xi2735-2744
Research on the relationship between profit level and R&D capital investment of China's pharmaceutical manufacturing industryZHANG Ya-jing, JIANG Wen-wen, CHEN Yu-wen2745-2751
Key points and discussion of the technical guidance for drug clinical trials of antidepressantsGENG Ying, ZHANG Hao, ZHAO De-heng, YANG Zhi-min2752-2754
A retrospective analysis of rodent carcinogenicity test results in the new drug non-clinical safety evaluationZHANG Su-cai, GU Ling-ling, YAO Da-lin, SUN Yun-xia, SUN Tao2755-2764
Challenges and suggestions for implementing marketing authorization holder system for preventive biological products in ChinaWANG Xue-wei, DAI Wei, FENG Xiao-chan, SHI Nan, YANG Yue2765-2769
Advances in clinical research of antitumor targeting drug anlotinibWANG Rui-qing, ZHANG Yan-hua2770-2774
Recent advances in the treatment targeting FXR for cholestatic liver diseaseLAN He-yan, TANG Yong, YAN Shu2775-2780